全文获取类型
收费全文 | 71706篇 |
免费 | 4272篇 |
国内免费 | 291篇 |
专业分类
耳鼻咽喉 | 983篇 |
儿科学 | 1479篇 |
妇产科学 | 1163篇 |
基础医学 | 9979篇 |
口腔科学 | 1656篇 |
临床医学 | 6918篇 |
内科学 | 15127篇 |
皮肤病学 | 1485篇 |
神经病学 | 7418篇 |
特种医学 | 3741篇 |
外国民族医学 | 11篇 |
外科学 | 12046篇 |
综合类 | 532篇 |
一般理论 | 17篇 |
预防医学 | 3530篇 |
眼科学 | 1114篇 |
药学 | 4329篇 |
中国医学 | 99篇 |
肿瘤学 | 4642篇 |
出版年
2023年 | 496篇 |
2022年 | 805篇 |
2021年 | 1722篇 |
2020年 | 1005篇 |
2019年 | 1534篇 |
2018年 | 1766篇 |
2017年 | 1409篇 |
2016年 | 1721篇 |
2015年 | 1975篇 |
2014年 | 2455篇 |
2013年 | 3057篇 |
2012年 | 4883篇 |
2011年 | 4964篇 |
2010年 | 2895篇 |
2009年 | 2685篇 |
2008年 | 4357篇 |
2007年 | 4430篇 |
2006年 | 4169篇 |
2005年 | 4223篇 |
2004年 | 3773篇 |
2003年 | 3637篇 |
2002年 | 3331篇 |
2001年 | 1219篇 |
2000年 | 1068篇 |
1999年 | 1053篇 |
1998年 | 751篇 |
1997年 | 605篇 |
1996年 | 510篇 |
1995年 | 406篇 |
1994年 | 389篇 |
1993年 | 322篇 |
1992年 | 514篇 |
1991年 | 507篇 |
1990年 | 471篇 |
1989年 | 440篇 |
1988年 | 420篇 |
1987年 | 361篇 |
1986年 | 350篇 |
1985年 | 341篇 |
1984年 | 332篇 |
1983年 | 267篇 |
1982年 | 224篇 |
1981年 | 175篇 |
1979年 | 238篇 |
1978年 | 189篇 |
1977年 | 180篇 |
1976年 | 171篇 |
1975年 | 197篇 |
1974年 | 201篇 |
1973年 | 188篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
72.
73.
74.
75.
Jonas T. Johnson MD Editor John K. Niparko MD Editor-in-Chief Paul A. Levine MD Editor David W. Kennedy MD Editor Pete Weber MD Editor-in-Chief Randal S. Weber MD Editor Michael S. Benninger MD Past Editor in Chief Richard M. Rosenfeld MD MPH Editor in Chief Robert J. Ruben MD Editor in Chief Richard J.H. Smith MD Editor in Chief Robert Thayer Sataloff MD DMA Editor in Chief Neil Weir MA FRCS Editor Emeritus 《Otolaryngology--head and neck surgery》2006,135(6):829-830
76.
Clear cell ependymoma is a rare and diagnostically challenging subtype of ependymoma, whose genetic features are essentially unknown. We studied 13 clear cell ependymomas (five cases WHO grade II, eight cases WHO grade III) by comparative genomic hybridization (CGH). Chromosomal imbalances were found in 12/13 cases. The most common aberrations overall were +1q (38%), -9 (77%), -3 (31%), and -22q (23%). Clear cell ependymomas of WHO grade II were characterized by -9 (40%), whereas WHO grade III cases mainly showed +1q (63%), and +13q (25%), as well as -9 (100%), -3 (38%), and -22q (25%). In contrast to other ependymal tumors, clear cell ependymomas of WHO grade II showed fewer imbalances than WHO grade III samples (1.4 vs 3.5 per case). Although some of the implicated chromosomes have previously been shown to be involved in other ependymoma variants, the striking frequency of +1q, -9, and -3 suggests that aberrations differ between clear cell and other types of ependymomas, in particular, for loss of chromosome 9 which can be regarded as the molecular hallmark of clear cell ependymomas. 相似文献
77.
T Andus V Gross A Holstege M Ott M Weber M David H Gallati W Gerok J Sch?lmerich 《Hepatology (Baltimore, Md.)》1992,16(3):749-755
Ascites and plasma concentrations of soluble tumor necrosis factor receptors p55 and p75 were measured in a prospective study in 34 patients (35 occasions of ascites) with hepatic (5 infected and 21 uninfected) and malignancy-related (9) ascites. All patients had high concentrations of both soluble tumor necrosis factor receptors in ascites and plasma; these were about 500 times higher than the corresponding tumor necrosis factor-alpha concentrations. Ascites levels of soluble tumor necrosis factor receptors p55 and soluble tumor necrosis factor receptors p75 were significantly elevated in patients with malignancy-related (p55: 26.0 +/- 8.6 ng/ml; p75: 20.5 +/- 17.4 ng/ml; mean +/- S.D.) and infected ascites (p55: 25.1 +/- 10.9 ng/ml, p75: 22.6 +/- 11.0 ng/ml) compared with patients with uncomplicated hepatic ascites (p55: 10.1 +/- 4.4 ng/ml; p75: 6.0 +/- 2.6 ng/ml). Patients with infected or malignancy-related ascites also showed higher soluble tumor necrosis factor receptor concentrations in plasma than did patients with plain hepatic ascites. Successful antibiotic treatment of peritonitis reduced soluble tumor necrosis factor receptor p55 and p75 ascites levels in three patients from 24.2 +/- 15.2 ng/ml to 10.7 +/- 1.9 ng/ml and from 20.2 +/- 14.4 ng/ml to 7.5 +/- 1.8 ng/ml, respectively. Soluble tumor necrosis factor receptors p55 and p75 at cutoff levels of 16.5 ng/ml and 9.5 ng/ml, respectively, differentiated between infected or malignant and plain hepatic ascites with diagnostic accuracies of 94% and 89%, respectively. They did not differentiate between infected and malignant ascites. The concentrations of soluble tumor necrosis factor receptor p55 were usually higher in ascites than in plasma in all subgroups of patients.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
78.
79.
W S Gibson T F Christian P A Pellikka T Behrenbeck R J Gibbons 《Journal of nuclear medicine》1992,33(12):2080-2085
The purpose of this study was to determine the relationship of changes in the severity and extent of hypoperfusion on serial tomographic 99mTc-sestamibi images with patency of the infarct related artery during acute myocardial infarction. We studied 109 patients with acute myocardial infarction using tomographic 99mTc-sestamibi imaging acutely and at 18-48 hr later. Perfusion defect extent and defect area, an index of defect severity, were measured on both studies. Both defect extent and defect area were significantly (p = 0.0001) greater for anterior infarctions than for inferior and lateral infarctions. By two factor analysis of variance, the change in defect area varied significantly with both infarct location (p = 0.0001) and patency of the infarct-related artery (p = 0.002). The change in defect extent also varied significantly with both infarct location (p = 0.0001) and with patency of the infarct-related artery (p = 0.004). In patients with inferior myocardial infarction, a change in defect extent or defect area of greater than 4% or 0.017, respectively, had a positive predictive accuracy of 96% and 93%, respectively, for the identification of a patent infarct artery. Therefore, sequential changes on tomographic 99mTc-sestamibi images are of potential value for the noninvasive assessment of patency of the infarct-related artery. 相似文献
80.
W S Silvers R A Ledoux W K Dolen M R Morrison H S Nelson R W Weber 《Annals of allergy》1992,69(5):421-426
Pollen patterns were compared between Vail, CO (8,200 feet elevation), Aspen, CO (7,900 feet) and Denver, CO (5,280 feet) from 1984 through 1988. Counts were obtained at all sites with a volumetric intermittent cycling rotating impaction sampler. Aspen and Denver were compared in 1984, and Vail and Denver from 1985 through 1988. While counts were generally lower in the mountain sites than Denver, certain pollens, especially trees, were quite high. Ragweed was essentially absent from Aspen and Vail, and chenopod-amaranth counts were very low. Cedar, pine, and aspen frequently pollinated despite active snowfall. 相似文献